Applications of [131I]m-iodobenzylguanidine ([131I]MIBG)
dc.contributor.author | Beierwaltes, William H. | en_US |
dc.date.accessioned | 2006-04-07T20:00:48Z | |
dc.date.available | 2006-04-07T20:00:48Z | |
dc.date.issued | 1987 | en_US |
dc.identifier.citation | Beierwaltes, William H. (1987)."Applications of [131I]m-iodobenzylguanidine ([131I]MIBG)." International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 14(3): 183-189. <http://hdl.handle.net/2027.42/26908> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B7GH9-4CDYPYP-2C/2/2bc469b2cc0c50306f03b5e61314252d | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/26908 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3312118&dopt=citation | en_US |
dc.description.abstract | The development of the aralkylguanidine [131I]m-iodobenzylguanidine ([131I]MIBG) in the University of Michigan Nuclear Medicine Division has led to diagnostic and therapeutic evaluations of all the neuroendocrine tumors. These tumors share the property of uptake, storage and release of [131I]MIBG uptake in chromaffin granules. This property has allowed the detection of pheochromocytomas, the detection of metastases in 46% of such patients, the treatment of malignant pheochromocytomas, the detection of neuroblastoma metastases, the treatment of neuroblastomas and the detection of a percent of apudomas. We have learned how to improve our results and this is discussed. | en_US |
dc.format.extent | 1067233 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Applications of [131I]m-iodobenzylguanidine ([131I]MIBG) | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Physics | en_US |
dc.subject.hlbsecondlevel | Nuclear Engineering and Radiological Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, U.S.A. | en_US |
dc.identifier.pmid | 3312118 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/26908/1/0000474.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0883-2897(87)90041-9 | en_US |
dc.identifier.source | International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.